Apollon Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,181
Closed -$220K 878
2022
Q4
$220K Sell
7,181
-7,277
-50% -$218K 0.02% 757
2022
Q3
$356K Sell
14,458
-401
-3% -$13.2K 0.03% 544
2022
Q2
$476K Buy
14,859
+5,088
+52% +$187K 0.04% 440
2022
Q1
$308K Sell
9,771
-527
-5% -$16.5K 0.02% 585
2021
Q4
$346K Buy
10,298
+3,009
+41% +$93.7K 0.03% 550
2021
Q3
$212K Buy
7,289
+421
+6% +$13.6K 0.03% 424
2021
Q2
$239K Buy
+6,868
New +$227K 0.04% 325

Other funds holding CC

Apollon Wealth Management's CC Position: Q1 2023 in Review

Apollon Wealth Management sold out of Chemours (CC) in Q1 2023, closing a stake of 7,181 shares — an estimated $220K sold.

Apollon Wealth Management first reported a position in CC in Q2 2021 and held it in 7 quarters. The position peaked at $476K in Q2 2022. 487 funds tracked by Wall St. Rank hold CC as of Q1 2023.

  • Apollon Wealth Management reported no remaining Chemours position as of Q1 2023 after selling out during the quarter.
  • Apollon Wealth Management sold 7,181 Chemours shares in Q1 2023, an estimated $220K.
  • Apollon Wealth Management first reported a position in Chemours in Q2 2021 and held it in 7 quarters.
  • Apollon Wealth Management's Chemours position peaked at $476K in Q2 2022.
  • 487 funds tracked by Wall St. Rank held Chemours as of Q1 2023.

Based on Apollon Wealth Management's 13F filing for Q1 2023, filed 16 May 2023.